- Home
- CBUS vs ICCC Comparison
CBUS vs ICCC Comparison
Compare CBUS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- ICCC
- Stock Information
- Founded
- CBUS 2010
- ICCC 1982
- Country
- CBUS United States
- ICCC United States
- Employees
- CBUS N/A
- ICCC N/A
- Industry
- CBUS Agricultural Chemicals
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- ICCC Health Care
- Exchange
- CBUS Nasdaq
- ICCC Nasdaq
- Market Cap
- CBUS 72.0M
- ICCC 60.1M
- IPO Year
- CBUS 2017
- ICCC 1987
- Fundamental
- Price
- CBUS $1.38
- ICCC $5.60
- Analyst Decision
- CBUS Strong Buy
- ICCC
- Analyst Count
- CBUS 3
- ICCC 0
- Target Price
- CBUS $22.00
- ICCC N/A
- AVG Volume (30 Days)
- CBUS 197.4K
- ICCC 6.8K
- Earning Date
- CBUS 11-06-2025
- ICCC 11-12-2025
- Dividend Yield
- CBUS N/A
- ICCC N/A
- EPS Growth
- CBUS N/A
- ICCC N/A
- EPS
- CBUS N/A
- ICCC 0.20
- Revenue
- CBUS $4,846,000.00
- ICCC $28,274,756.00
- Revenue This Year
- CBUS $17.67
- ICCC N/A
- Revenue Next Year
- CBUS $63.43
- ICCC N/A
- P/E Ratio
- CBUS N/A
- ICCC $29.40
- Revenue Growth
- CBUS 63.66
- ICCC 21.75
- 52 Week Low
- CBUS $1.20
- ICCC $3.34
- 52 Week High
- CBUS $6.10
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- CBUS 48.79
- ICCC 35.75
- Support Level
- CBUS $1.32
- ICCC $5.59
- Resistance Level
- CBUS $1.41
- ICCC $6.42
- Average True Range (ATR)
- CBUS 0.08
- ICCC 0.27
- MACD
- CBUS 0.01
- ICCC -0.07
- Stochastic Oscillator
- CBUS 52.31
- ICCC 0.71
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.